PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gain understanding of how PET-MR (positron emission
tomography-magnetic resonance imaging) using the substance 18F-DCFPyL (PyL) may help in
diagnosing prostate cancer and in determining the stage of prostate cancer before surgery.